Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer’s disease: the Altoida large cohort study

Conventional neuropsychological assessments for Alzheimer’s disease are burdensome and inaccurate at detecting mild cognitive impairment and predicting Alzheimer’s disease risk. Altoida’s Digital Neuro Signature (DNS), a longitudinal cognitive test consisting of two active digital biomarker metrics,...

Descripción completa

Detalles Bibliográficos
Autores principales: Meier, Irene B., Buegler, Max, Harms, Robbert, Seixas, Azizi, Çöltekin, Arzu, Tarnanas, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225898/
https://www.ncbi.nlm.nih.gov/pubmed/34168269
http://dx.doi.org/10.1038/s41746-021-00470-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225898/
https://www.ncbi.nlm.nih.gov/pubmed/34168269
http://dx.doi.org/10.1038/s41746-021-00470-z

Ejemplares similares